TUNNEL assay representing apoptosis in <i>C</i>. <i>auris</i>. by Hammad Alam (530008)

Subjects:

Seasonal variation of fish distribution in vertical structure expressed as the relationship between <i>Sv</i> (volume backscattering strength) and <i>D</i> (depth of fish school),... by Yanhui Zhu (6697751)

The HMR C-terminus is required for HMR localization in proximity to centromeres and HP1a-bound chromatin (related to Fig 4). by Andrea Lukacs (3752956)

Comparison of physiological and perceptual measures of national-level rowing athletes taken during a 10-min submaximal rowing test performed at 95% of 30-min time-trial average pow... by Calvin P. Philp (12095878)

Subjects:

Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation. by Cynthia Alsayyah (18452506)

Subjects:

Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis. by Garett Dunsmore (11021169)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

The rate the bias decreases with sample duration is higher for cells with higher activity levels. by Liron Sheintuch (12078310)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Activation is greater for youth in the before prize condition (<i>n</i> = 226) vs. after prize condition (<i>n</i> = 220) during large win > small win trials in the MTwiNS sample (... by Melissa K. Peckins (12042132)

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

Gravity-Guided Growth of Large-Area High-Quality Two-Dimensional Ruddlesden–Popper Perovskite Thin Films for Stable Ultraviolet Photodetectors by Tong Guo (158839)

Supplementary data: In vitro amplification of whole large plasmids via transposon-mediated oriC insertion by Masayuki Su'estugu (11359558)

“…</b> Purified pTT8 plasmid or the amplification product of the pTT8 plasmid generated by Tn-RCR were incubated at 37ºC for 3 h with (cut) or without (no cut) <i>Kpn</i>I and <i>Nhe</i>I. …”

Decreased MBP levels in the brain in <i>Large</i>^{<i>myd/myd</i>} mice. by Shigefumi Morioka (8893511)

“…Decreased expression levels of MBP were observed in <i>Large</i>^{<i>myd/myd</i>} mice compared with those in control mice. …”

Drug-induced decrease of cell anisotropy reduces pattern fidelity. by Camille Curantz (7456499)

“…<b>(B)</b> Quantifications of primordia spacing variability on phalloïdin-stained control flat skins (explant; triangles) and LatA-treated cultured explants (+LatA; squares) of Japanese quail embryos showed that LatA treatment caused a significant decrease in pattern fidelity at condensation stage (explants, <i>n</i> = 9; +LatA, <i>n</i> = 9; unpaired 2-tailed <i>t</i> test; <i>p</i> = 0.0233) and differentiation stage (explants, <i>n</i> = 8; +LatA, <i>n</i> = 9; <i>p</i> = 0.002). …”

S6 Fig - by Melissa K. Peckins (12042132)